Degarelix Comprehensive Study by Type (120 mg per vial, 80 mg per vial), Application (Hospital, Drug store), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2028

Name: Degarelix Comprehensive Study by Type (120 mg per vial, 80 mg per vial), Application (Hospital, Drug store), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2028
Brand: AMA Research
SKU: 83989
Price: 3500 USD
Availability: InStock
Rating: 4.5 (3 reviews)

Degarelix Market by XX Submarkets | Forecast Years 2023-2028

Summary
Market Segments
Table of Content
List of Table & Figures
Players Profiled

Summary

What is Degarelix Market Scope?

Degarelix injection is used to treat advanced prostate cancer (cancer that begins within the prostate [a male reproductive gland]). Degarelix injection is in a class of medications known as gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the number of testosterone (a male hormone) made by the body. this could slow or stop the spread of prostate cancer cells that require testosterone to grow.

Influencing Trend:

Increase In Recommendation from The Professionals

Market Growth Drivers:

Increase In Number of Male Populations and Increase In Disposable Income

Challenges:

Lack Of Awareness in The Developing Regions

Restraints:

Side Effects of The Injection

Opportunities:

Increase In Research and Development Activities

The Degarelix market study is being classified by Type (120 mg per vial and 80 mg per vial), by Application and major geographies with country level break-up.

Degarelix that has been developed for prostate cancer is in demand due to the increasing number of prostate gland cancer cases in the countries. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Degarelix market throughout the predicted period.

Ferring (United States) are some of the key players profiled in the study.

Segmentation Analysis

Analyst at AMA have segmented the market study of Global Degarelix market by Type, Application and Region.

On the basis of geography, the market of Degarelix has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies

In May 2023, Teva Pharmaceutical Industries Ltd. partnered with Accord Healthcare Limited, a global pharmaceutical company specializing in generics and biosimilars, to develop and commercialize a generic version of degarelix. The partnership aimed to expand access to degarelix and provide more affordable treatment options for patients with prostate cancer.
In August 2023, Degarelix was included in the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Prostate Cancer, recognizing its established efficacy and safety in the treatment of advanced PCa.

Key Target Audience

Manufacturers of Degarelix, Suppliers and distributors of Degarelix, Governmental and Regulatory bodies and End-Users

Degarelix Market Study: Important Years

Attributes	Details
Study Period	2018-2028
Base Year	2022
Forecast Period	2023-2028
Historical Period	2018-2022
Unit	Value (USD Million)
Customization Scope	Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility

Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Degarelix Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Degarelix industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:

The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Market Segments

Report Objectives / Segmentation Covered

By Type

120 mg per vial
80 mg per vial

By Application

Hospital
Drug store

By Distribution Channel

Online
Offline

By Regions

South America
- Brazil
- Argentina
- Rest of South America
Asia Pacific
- China
- Japan
- India
- South Korea
- Taiwan
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- Italy
- United Kingdom
- Netherlands
- Rest of Europe
MEA
- Middle East
- Africa
North America
- United States
- Canada
- Mexico

Table of Content

List of Tables & Figures

List of Tables

List of Figures

Figure 1. Porters Five Forces
Figure 2. Supply/Value Chain
Figure 3. PESTEL analysis
Figure 4. Global Degarelix: by Type USD Million (2017-2022)
Figure 5. Global Degarelix: by Application USD Million (2017-2022)
Figure 6. Global Degarelix: by Distribution Channel USD Million (2017-2022)
Figure 7. South America Degarelix Share (%), by Country
Figure 8. Asia Pacific Degarelix Share (%), by Country
Figure 9. Europe Degarelix Share (%), by Country
Figure 10. MEA Degarelix Share (%), by Country
Figure 11. North America Degarelix Share (%), by Country
Figure 12. Global Degarelix: by Type USD/Units (2017-2022)
Figure 13. Global Degarelix share by Players 2022 (%)
Figure 14. BCG Matrix for key Companies
Figure 15. Ferring (United States) Revenue, Net Income and Gross profit
Figure 16. Ferring (United States) Revenue: by Geography 2022
Figure 17. Global Degarelix: by Type USD Million (2023-2028)
Figure 18. Global Degarelix: by Application USD Million (2023-2028)
Figure 19. Global Degarelix: by Distribution Channel USD Million (2023-2028)
Figure 20. South America Degarelix Share (%), by Country
Figure 21. Asia Pacific Degarelix Share (%), by Country
Figure 22. Europe Degarelix Share (%), by Country
Figure 23. MEA Degarelix Share (%), by Country
Figure 24. North America Degarelix Share (%), by Country
Figure 25. Global Degarelix: by Type USD/Units (2023-2028)

Companies Mentioned

List of companies from research coverage that are profiled in the study

Ferring (United States)

Select User Access Type

Single User
$ 3500
Corporate User
$ 6400

Key Highlights of Report

Dec 2023 208 Pages 87 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing

Check Discount Now

Global Degarelix Market Quantitative research analysis

Global Degarelix Market Qualitative Industry Analysis

DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?

"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Degarelix Market Report?

Have a Query? Click Here

Degarelix Comprehensive Study by Type (120 mg per vial, 80 mg per vial), Application (Hospital, Drug store), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2028

Degarelix Market by XX Submarkets | Forecast Years 2023-2028

Report Objectives / Segmentation Covered

Talk to Our Experts

Want to Customize Study?

Frequently Asked Questions (FAQ):

Who are the prominent players of the Global Degarelix market?

What are the top priorities to focus for Degarelix market growth?

Who are the potential customers in Degarelix Market?

Know More About Global Degarelix Market Report?

Subscribe our newsletter now

Degarelix Comprehensive Study by Type (120 mg per vial, 80 mg per vial), Application (Hospital, Drug store), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2028

Degarelix Market by XX Submarkets | Forecast Years 2023-2028

Report Objectives / Segmentation Covered

Talk to Our Experts

Want to Customize Study?

Frequently Asked Questions (FAQ):

Who are the prominent players of the Global Degarelix market?

What are the top priorities to focus for Degarelix market growth?

Who are the potential customers in Degarelix Market?

Know More About Global Degarelix Market Report?

Other Related Reports